14 news items
Jazz Pharmaceuticals Provides Update on Phase 2b Trial of Investigational Suvecaltamide (JZP385) in Essential Tremor
JAZZ
20 Jun 24
) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life
MAIA Biotechnology (MAIA): Pioneering New Frontiers in NSCLC Treatment with THIO
BMRN
EXEL
GMAB
7 Jun 24
damage in cancer cells, triggering immune responses that lead to selective cancer cell death. This innovative mechanism not only disrupts the fundamental
Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024
JAZZ
1 Jun 24
Pharmaceuticals plc (NASDAQ:JAZZ) is a global biopharma company whose purpose is to innovate
Jazz Pharmaceuticals Showcases Pioneering Research in Sleep Medicine at SLEEP 2024
JAZZ
30 May 24
(NASDAQ:JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients
Jazz Pharmaceuticals to Participate in Upcoming June Investor Conferences
JAZZ
29 May 24
(NASDAQ:JAZZ) is a global biopharma company whose purpose is to innovate to transform the lives of patients
7ugbtju2seahakci aqnqct8x6
JAZZ
29 May 24
is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases
t481ksbb f0hnuo5
JAZZ
22 May 24
industry— full of creative, collaborative and innovative people—is uniquely positioned to make a meaningful difference
wo0qrr9e894xe6k7ha2engshbeaxqu3bxrivtai5jlfwc
ABBV
AMGN
CURLF
18 May 24
in innovative treatments like
48idh23
ABBV
CRBP
CRDL
14 May 24
driving innovation
i9jh6qxyvz cciw
AMGN
CASI
JAZZ
7 May 24
the leadership of Scott Plesha as Chief Executive Officer. Pelthos is focused on the commercialization of innovative, safe, and efficacious therapeutic products
tezj oobi92urtzb
JAZZ
1 May 24
(NASDAQ:JAZZ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We
pa5 cgr50nzir6qlr
JAZZ
24 Apr 24
at this year's meeting demonstrate our commitment to advancing our portfolio of innovative oncology products and investigational therapies at all stages
qcb6zvy712 xdzdjdsz2f0e
JAZZ
17 Apr 24
(NASDAQ:JAZZ) is a global biopharma company whose purpose is to innovate to transform the lives of patients
itye8mbx21u
JAZZ
10 Apr 24
biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing
- Prev
- 1
- Next